Clinical Pathology Labs Inc San Antonio, TX - 78232

Clinical Pathology Labs Inc is categorized under Counseling Services in San Antonio, TX and active since 2004.

Clinical Pathology Labs Inc was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Counseling Services business, which does work in the B2C market, and is classified as a Counseling Services, under code number 6215110 by the NAICS.

If you are seeking more information, feel free to contact Franklin R Brooks at the company’s branch by writing to 14615 San Pedro Avenue # 240, San Antonio, Texas TX 78232 or by phoning (210) 495-5356. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Clinical Pathology Labs Inc
Contact Person: Franklin R Brooks
Address: 14615 San Pedro Avenue # 240, San Antonio, Texas 78232
Phone Number: (210) 495-5356
Website Address: cpllabs.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2004
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Counseling Services
SIC Code: 8322
NAICS Code: 6215110
Share This Business:

Clinical Pathology Labs Inc was started in 2004 to provide professional Counseling Services under the SIC code 8322 and NAICS code 6215110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Franklin R Brooks for inquiries that concern Clinical Pathology Labs Inc by calling the company number (210) 495-5356, as your correspondence is most welcome. Additionally, the physical location of the branch of Clinical Pathology Labs Inc can be found at the coordinates 29.57277,-98.479668 as well as the street address 14615 San Pedro Avenue # 240 in San Antonio, Texas 78232.

For its online presence, you may visit Clinical Pathology Labs Inc’s website at cpllabs.com and engage with its social media outlets through on Twitter and on Facebook.